Activities of Newer Fluoroquinolones against Ciprofloxacin-Resistant Streptococcus pneumoniae

The incidence of ciprofloxacin resistance in Streptococcus pneumoniae is low but steadily increasing, which raises concerns regarding the clinical impact of potential cross-resistance with newer fluoroquinolones. To investigate this problem, we utilized an in vitro pharmacodynamic model and compared...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Coyle, Elizabeth A., Kaatz, Glenn W., Rybak, Michael J.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 2001
Teme:	Experimental Therapeutics
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90528/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11353608/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.6.1654-1659.2001
Oznake:	Označite Brez oznak, prvi označite!